Please assess the completion status of the following clinical trial:

Trial Title: Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Diagnosis of prostate adenocarcinoma~  * Metastatic disease~* Must have failed initial hormonal therapy and have disease progression after at least one chemotherapy regimen\*, meeting any of the following criteria:~  * Progressive PSA ≥ 5 ng/mL, as evidenced by 2 separate measurements taken ≥ 2 weeks apart with the second PSA measurement greater than the first one and PSA measurement at screening greater than the first one~ * Progressive measurable disease (e.g., changes in the size of lymph nodes or parenchymal masses or appearance of new lesions on physical examination or x-ray/CT scan) with a PSA level at screening ≥ 5 ng/mL~ * Progressive bone metastasis (e.g., presence of new lesions on a bone scan) with a PSA level at screening ≥ 5 ng/mL NOTE: \*Prior chemotherapy must include a taxane therapy, but disease progression does not have to follow taxane therapy~* Patients must maintain primary androgen ablation (hormonal) therapy AND experience disease progression while not receiving antiandrogen therapy~PATIENT CHARACTERISTICS:~* ECOG performance status 0-1~* Life expectancy ≥ 6 months~* Absolute neutrophil count ≥ 1,500/mm\^3~* Platelet count ≥ 100,000/mm\^3~* WBC ≥ 3,500/mm\^3~* Bilirubin ≤ 1.2 mg/dL~* Creatinine ≤ 1.5 mg/dL~* SGOT or SGPT ≤ 1.5 times upper limit of normal~* No other prior malignancy unless treated with curative intent and free of disease for the time period considered appropriate for the specific cancer~* No uncontrolled hypertension~* No active infections~* No known HIV positivity~* No uncontrolled medical condition that would preclude study therapy~* No diagnosis of major depression or suicidal ideation~* No problems with oral absorption~PRIOR CONCURRENT THERAPY:~* See Disease Characteristics~* More than 4 weeks since prior surgery or radiotherapy and recovered~* At least 4 weeks since prior flutamide~* At least 6 weeks since prior bicalutamide~* No prior or concurrent herbal supplements or thiazide diuretics~* No other concurrent investigational or commercial agents or therapies

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Study Arms:
- licorice root extract and docetaxel (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).